Splanchnic vasodilatation, a direct result of portal hypertension, leads to a decrease in effective arterial blood volume (EABV), which then activates homeostatic systems such as the renin-angiotensin system and sympathetic nervous system to promote sodium and water retention and vasoconstriction. The gene discussed is REN; the disease is portal hypertension.